| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.44 | 7e-31 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-14 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-11 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |